Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence.
about
Pharmaceutical policies: effects of policies regulating drug insurance schemesPharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesChallenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study.Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countriesImpact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studiesQuality use of medicines within universal health coverage: challenges and opportunitiesMedicines and universal health coverage: challenges and opportunitiesAntibiotic prescribing for upper respiratory tract infections in the Asia-Pacific region: A brief review.The case of pharmacist prescribing policy in IsraelProvider payment in community-based health insurance schemes in developing countries: a systematic review.An Implementation Research Approach to Evaluating Health Insurance Programs: Insights from IndiaPharmaceutical policies used by private health insurance companies in Saudi ArabiaBibliographic review of research publications on access to and use of medicines in low-income and middle-income countries in the Eastern Mediterranean Region: identifying the research gaps.Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Achieving universal health coverage-the case of Zhuhai city.Financial arrangements for health systems in low-income countries: an overview of systematic reviews.Governance arrangements for health systems in low-income countries: an overview of systematic reviews.
P2860
Q24188173-7D71C913-1AF3-4625-A58F-5EF003310F34Q24193097-C17909F4-5D2D-4705-B1C7-BFACDC933E27Q30385819-B7FD7EDB-F96D-4710-85DE-87BCD3046BECQ30393427-027C3923-F342-43F2-ACAC-B68024B0C9B2Q30394441-5D21037B-6451-436B-9DD7-F060899A9745Q33697280-32AE2BF6-1B95-4AE2-AC28-A97437910A19Q34151454-88FDD9D0-E1C3-46F1-88B1-66F2AB3C0FB3Q35149420-187F913D-341F-48F8-872D-80E80B6F50D1Q35443148-DA3CD15E-2F5C-4255-B7A2-48771F968623Q36361746-B4298A29-DA12-46FD-A2CB-B58A0EED4B5DQ36647111-27692FBF-4E4C-46FE-8508-337AE6251B07Q36854302-FEC64011-2ADD-42B5-A505-391D65E2497AQ37098824-937CA253-EFEF-4DF8-8BF3-6D4A62358312Q37228999-D6CAAC1B-C657-4C7E-B2D0-10F5B7BA49D9Q38285316-604B6F27-397F-41C3-87F2-DF23EB9F42C6Q39139933-5977FAFE-A11B-4E9D-8C11-E22E86F965D9Q42722998-6D64C4F4-72B0-4ED0-B037-3A9D37BA184DQ42723022-EE225239-1E68-4CC8-AB72-BE87FA82C186
P2860
Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Active pharmaceutical manageme ...... ic review of current evidence.
@en
Active pharmaceutical manageme ...... ic review of current evidence.
@nl
type
label
Active pharmaceutical manageme ...... ic review of current evidence.
@en
Active pharmaceutical manageme ...... ic review of current evidence.
@nl
prefLabel
Active pharmaceutical manageme ...... ic review of current evidence.
@en
Active pharmaceutical manageme ...... ic review of current evidence.
@nl
P2093
P1433
P1476
Active pharmaceutical manageme ...... ic review of current evidence.
@en
P2093
Anita Wagner
Catherine Vialle-Valentin
Laura Faden
P304
P356
10.1016/J.HEALTHPOL.2010.10.020
P577
2010-12-24T00:00:00Z